STANFORD UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-11-11

Employees: 10K

Market Cap: -

Website: http://www.stanford.edu

Clinical Trials

To Evaluate the Safety and Efficacy for GORE TAG Thoracic Endoprosthesis in the Treatment of Thoracic Aortic Disease

Phase 3

Completed

Conditions: Aneurysm, Dissecting
Aortic Aneurysm, Thoracic

Interventions: Device: Endovascular Stent-graft repair of descending thoracic aorta

First Posted Date: 2008-09-22

Last Posted Date: 2017-03-01

Lead Sponsor: Stanford University

Target Recruit Count: 100

Registration Number: NCT00757003

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT

Early Phase 1

Terminated

Conditions: Breast Cancer
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Breast Cancer Metastatic Breast Cancer

Interventions: Drug: Iodine-124
Radiation: PET/CT with Iodine-124

First Posted Date: 2008-07-31

Last Posted Date: 2017-10-11

Lead Sponsor: Stanford University

Target Recruit Count: 7

Registration Number: NCT00725946

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Combined F-18 NaF and F-18 FDG PET/CT for Evaluation of Malignancy

Completed

Conditions: Neoplasms

First Posted Date: 2008-07-30

Last Posted Date: 2019-09-18

Lead Sponsor: Stanford University

Target Recruit Count: 214

Registration Number: NCT00725387

Locations: 🇮🇳
Apollo Hospital, Chennai, India
🇩🇰
Aalborg Hospital, Aalborg, Denmark
🇿🇦
Pretoria Academic Hospital, Pretoria, South Africa

and more 2 locations

Subcutaneous Botulinum Toxin for Cutaneous Allodynia

Not Applicable

Completed

Conditions: Pain

Interventions: Drug: Placebo - Saline
Drug: Botulinum Toxin A

First Posted Date: 2008-07-30

Last Posted Date: 2017-10-25

Lead Sponsor: Stanford University

Target Recruit Count: 84

Registration Number: NCT00725322

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Treatment of Schizoaffective Disorder Using Mifepristone

Phase 2

Terminated

Conditions: Depressive Disorder
Psychotic Disorders
Depressive Disorder, Major

Interventions: Drug: Placebo Oral Tablet
Drug: Mifepristone

First Posted Date: 2008-07-30

Last Posted Date: 2017-03-24

Lead Sponsor: Stanford University

Target Recruit Count: 12

Registration Number: NCT00725270

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

A Study to Evaluate the Efficacy of an Oral Medication in the Treatment and Prevention of Digital Ulcers in Patients With Systemic Sclerosis (Scleroderma).

Not Applicable

Completed

Conditions: Scleroderma, Systemic
n Ulcer

Interventions: Drug: Ambrisentan

First Posted Date: 2008-07-30

Last Posted Date: 2017-03-31

Lead Sponsor: Stanford University

Target Recruit Count: 20

Registration Number: NCT00725361

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Effect of IV Lidocaine Infusions on Pain

Not Applicable

Completed

Conditions: Pain

Interventions: Drug: Intravenous lidocaine

First Posted Date: 2008-07-30

Last Posted Date: 2019-02-15

Lead Sponsor: Stanford University

Target Recruit Count: 71

Registration Number: NCT00725504

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Assessing the da Vinci® Robotic Surgical System for Surgery of the Upper Aerodigestive Tract

Not Applicable

Terminated

Conditions: Laryngeal Neoplasms
Hypopharyngeal Neoplasms
Head and Neck Cancers

Interventions: Device: da Vinci Surgical Robot Platform
Procedure: Transoral Robotic Surgery

First Posted Date: 2008-07-24

Last Posted Date: 2016-11-03

Lead Sponsor: Stanford University

Target Recruit Count: 9

Registration Number: NCT00721539

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Use of Otoscope as a Non-invasive Tool for Diagnosis of Pilomatricoma

Completed

Conditions: Pilomatrixoma

First Posted Date: 2008-07-15

Last Posted Date: 2024-12-27

Lead Sponsor: Stanford University

Target Recruit Count: 4

Registration Number: NCT00715819

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

Rituximab for Pediatric Renal Transplant Rejection

Phase 2

Completed

Conditions: Kidney Transplantation

First Posted Date: 2008-06-16

Last Posted Date: 2008-12-23

Lead Sponsor: Stanford University

Target Recruit Count: 20

Registration Number: NCT00697996

Locations: 🇺🇸
Stanford University School of Medicine, Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy